• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.常染色体显性II型骨硬化症(阿尔伯斯-尚伯格病)定位于染色体16p13.3。
Am J Hum Genet. 2001 Sep;69(3):647-54. doi: 10.1086/323132. Epub 2001 Jul 23.
2
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.常染色体显性遗传性骨硬化症(阿尔伯斯-尚伯格病)的一个基因定位于1号染色体短臂2区1带。
Am J Hum Genet. 1997 Aug;61(2):363-9. doi: 10.1086/514844.
3
Locus heterogeneity of autosomal dominant osteopetrosis (ADO).常染色体显性遗传性骨硬化症(ADO)的基因座异质性
J Clin Endocrinol Metab. 1999 Mar;84(3):1047-51. doi: 10.1210/jcem.84.3.5578.
4
Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis.II型常染色体显性遗传性骨硬化症存在基因异质性的进一步证据。
J Bone Miner Res. 2000 Oct;15(10):1900-4. doi: 10.1359/jbmr.2000.15.10.1900.
5
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.阿尔伯斯-尚伯格病(常染色体显性遗传性骨硬化症II型)由ClCN7氯通道基因突变引起。
Hum Mol Genet. 2001 Dec 1;10(25):2861-7. doi: 10.1093/hmg/10.25.2861.
6
Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13.导致I型常染色体显性骨硬化症的基因定位于11号染色体q12 - 13区域。
J Bone Miner Res. 2002 Jun;17(6):1111-7. doi: 10.1359/jbmr.2002.17.6.1111.
7
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.II型常染色体显性遗传性骨硬化症(阿尔伯斯-尚伯格病):42例患者的临床及影像学表现
Bone. 2000 Jan;26(1):87-93. doi: 10.1016/s8756-3282(99)00244-6.
8
Two novel mutations of CLCN7 gene in Chinese families with autosomal dominant osteopetrosis (type II).中国常染色体显性遗传性骨硬化症(II型)家系中CLCN7基因的两个新突变
J Bone Miner Metab. 2016 Jul;34(4):440-6. doi: 10.1007/s00774-015-0682-2. Epub 2015 Jun 9.
9
Spectrum of Skeletal Imaging Features in Osteopetrosis: Inheritance Pattern and Radiological Associations.成骨不全症骨骼影像学表现的范围:遗传模式和放射学关联。
Genes (Basel). 2022 Oct 28;13(11):1965. doi: 10.3390/genes13111965.
10
A case of cavernous sinus thrombophlebitis and meningitis as a complication in osteopetrosis.1例以海绵窦血栓性静脉炎和脑膜炎为并发症的骨硬化症。
J Bone Metab. 2014 Aug;21(3):227-32. doi: 10.11005/jbm.2014.21.3.227. Epub 2014 Aug 31.

引用本文的文献

1
Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review.用于治疗骨质石化症的碳酸酐酶II激活剂:综述
Curr Issues Mol Biol. 2023 Feb 6;45(2):1373-1386. doi: 10.3390/cimb45020089.
2
Autosomal dominant osteopetrosis type II resulting from a mutation in the gene: A case report.由该基因突变导致的常染色体显性遗传II型骨硬化症:一例报告。
World J Clin Cases. 2022 Jul 16;10(20):6936-6943. doi: 10.12998/wjcc.v10.i20.6936.
3
A Novel Variant in Regulates the Coupling of Angiogenesis and Osteogenesis.中的一种新型变体调节血管生成与骨生成的耦合。
Front Cell Dev Biol. 2020 Nov 16;8:599826. doi: 10.3389/fcell.2020.599826. eCollection 2020.
4
The Genetic Architecture of High Bone Mass.高骨量的遗传结构。
Front Endocrinol (Lausanne). 2020 Oct 29;11:595653. doi: 10.3389/fendo.2020.595653. eCollection 2020.
5
Inherited disorders of lysosomal membrane transporters.溶酶体膜转运蛋白遗传性疾病。
Biochim Biophys Acta Biomembr. 2020 Dec 1;1862(12):183336. doi: 10.1016/j.bbamem.2020.183336. Epub 2020 May 8.
6
A Case of Autosomal Dominant Osteopetrosis Type 2 with a Gene Mutation.一例伴有基因突变的常染色体显性2型骨硬化症病例。
J Clin Res Pediatr Endocrinol. 2019 Nov 22;11(4):439-443. doi: 10.4274/jcrpe.galenos.2019.2018.0229. Epub 2019 Feb 14.
7
Fractures in patients with osteopetrosis, insights from a single institution.成骨不全症患者的骨折:单中心经验
Int Orthop. 2019 Jun;43(6):1297-1302. doi: 10.1007/s00264-018-4167-5. Epub 2018 Oct 4.
8
Genetic Analysis of in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis.一名患有II型常染色体显性骨硬化症老年女性患者的基因分析
Endocrinol Metab (Seoul). 2018 Sep;33(3):380-386. doi: 10.3803/EnM.2018.33.3.380.
9
Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2.在中国一个患有常染色体显性遗传骨硬化症2型的汉族家庭中鉴定出新型CLCN7突变。
Mol Pain. 2016 Jun 20;12. doi: 10.1177/1744806916652628. Print 2016.
10
Osteomyelitis of the mandible in a patient with osteopetrosis. Case report and review of the literature.一名患有骨硬化症患者的下颌骨骨髓炎。病例报告及文献综述。
J Maxillofac Oral Surg. 2013 Mar;12(1):94-9. doi: 10.1007/s12663-011-0196-y. Epub 2011 Apr 20.

本文引用的文献

1
Osteopetrosis: review of dominant cases and frequency in a Brazilian state.骨硬化症:巴西一州显性病例及发病率综述
Acta Genet Med Gemellol (Roma). 1961 Jul;10:353-8. doi: 10.1017/s1120962300016954.
2
Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.氯离子通道ClC-7的缺失会导致小鼠和人类患骨硬化症。
Cell. 2001 Jan 26;104(2):205-15. doi: 10.1016/s0092-8674(01)00206-9.
3
Further evidence for genetic heterogeneity within type II autosomal dominant osteopetrosis.II型常染色体显性遗传性骨硬化症存在基因异质性的进一步证据。
J Bone Miner Res. 2000 Oct;15(10):1900-4. doi: 10.1359/jbmr.2000.15.10.1900.
4
Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.液泡H(+)-ATP酶a3亚基的突变会导致婴儿恶性骨硬化症。
Hum Mol Genet. 2000 Aug 12;9(13):2059-63. doi: 10.1093/hmg/9.13.2059.
5
Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.液泡质子泵的TCIRG1亚基缺陷是人类常染色体隐性骨硬化症的一个子集的病因。
Nat Genet. 2000 Jul;25(3):343-6. doi: 10.1038/77131.
6
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients.II型常染色体显性遗传性骨硬化症(阿尔伯斯-尚伯格病):42例患者的临床及影像学表现
Bone. 2000 Jan;26(1):87-93. doi: 10.1016/s8756-3282(99)00244-6.
7
Locus heterogeneity of autosomal dominant osteopetrosis (ADO).常染色体显性遗传性骨硬化症(ADO)的基因座异质性
J Clin Endocrinol Metab. 1999 Mar;84(3):1047-51. doi: 10.1210/jcem.84.3.5578.
8
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.常染色体显性遗传性骨硬化症(阿尔伯斯-尚伯格病)的一个基因定位于1号染色体短臂2区1带。
Am J Hum Genet. 1997 Aug;61(2):363-9. doi: 10.1086/514844.
9
Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13).一个导致高骨量的基因与人类11号染色体(11q12 - 13)的连锁关系。
Am J Hum Genet. 1997 Jun;60(6):1326-32. doi: 10.1086/515470.
10
Recent developments in the understanding of the pathophysiology of osteopetrosis.关于骨质石化症病理生理学认识的最新进展。
Eur J Endocrinol. 1996 Feb;134(2):143-56. doi: 10.1530/eje.0.1340143.

常染色体显性II型骨硬化症(阿尔伯斯-尚伯格病)定位于染色体16p13.3。

Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.

作者信息

Bénichou O, Cleiren E, Gram J, Bollerslev J, de Vernejoul M C, Van Hul W

机构信息

Laboratoire INSERM U 349, Hôpital Lariboisière, Paris.

出版信息

Am J Hum Genet. 2001 Sep;69(3):647-54. doi: 10.1086/323132. Epub 2001 Jul 23.

DOI:10.1086/323132
PMID:11468688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1235505/
Abstract

The osteopetroses are a heterogeneous group of conditions characterized by a bone-density increase due to impaired bone resorption. As well as the two or more autosomal recessive types, two autosomal dominant forms of osteopetrosis, differentiated by clinical and radiological signs, are described. Autosomal dominant osteopetrosis (ADO) type II, also known as "Albers-Schönberg disease," is characterized by sclerosis, predominantly involving the spine (vertebral end-plate thickening, or Rugger-Jersey spine), the pelvis ("bone-within-bone" structures), and the skull base. An increased fracture rate can be observed in these patients. By linkage analysis, the presence, on chromosome 1p21, of a gene causing ADO type II was previously suggested. However, analysis of further families with ADO type II indicated genetic heterogeneity within ADO type II, with the chromosome 1p21 locus being only a minor locus. We now perform a genomewide linkage scan of a French extended family with ADO type II, which allows us to localize an ADO type II gene on chromosome 16p13.3. Analysis of microsatellite markers in five further families with ADO type II could not exclude this chromosomal region. A summed maximum LOD score of 12.70 was generated with marker D16S3027, at a recombination fraction (straight theta) of 0. On the basis of the key recombinants in the families, a candidate region of 8.4 cM could be delineated, flanked by marker D16S521, on distal side, and marker D16S423, on the proximal side. Surprisingly, one of the families analyzed is the Danish family previously suggested to have linkage to chromosome 1p21. Linkage to chromosome 16p13.3 clearly cannot be excluded in this family, since a maximum LOD score of 4.21 at theta=0 is generated with marker D16S3027. Because at present no other family with ADO type II has proved to have linkage to chromosome 1p21, we consider the most likely localization of the disease-causing gene in this family to be to chromosome 16p13.3. This thus reopens the possibility that ADO type II is genetically homogeneous because of a single gene on chromosome 16p13.3.

摘要

骨硬化症是一组异质性疾病,其特征是由于骨吸收受损导致骨密度增加。除了两种或更多种常染色体隐性类型外,还描述了两种常染色体显性形式的骨硬化症,可通过临床和放射学体征进行区分。常染色体显性II型骨硬化症(ADO),也称为“阿尔伯斯-舍恩伯格病”,其特征为硬化,主要累及脊柱(椎体终板增厚,即鲁格-泽西脊柱)、骨盆(“骨中骨”结构)和颅底。这些患者的骨折率会升高。通过连锁分析,先前曾提示在1号染色体短臂2区1带存在一个导致II型ADO的基因。然而,对更多II型ADO家系的分析表明,II型ADO存在遗传异质性,1号染色体短臂2区1带位点只是一个次要位点。我们现在对一个患有II型ADO的法裔大家系进行全基因组连锁扫描,这使我们能够将II型ADO基因定位到16号染色体短臂1区3带。对另外五个患有II型ADO的家系中的微卫星标记进行分析,无法排除该染色体区域。标记D16S3027在重组率(θ值)为0时产生的最大对数优势(LOD)分数总和为12.70。根据家系中的关键重组体,可划定一个8.4厘摩的候选区域,其远端为标记D16S521,近端为标记D16S423。令人惊讶的是,所分析的家系之一是先前曾提示与1号染色体短臂2区1带连锁的丹麦家系。由于标记D16S3027在θ=0时产生的最大LOD分数为4.21,显然不能排除该家系与16号染色体短臂1区3带的连锁关系。因为目前没有其他患有II型ADO的家系被证明与1号染色体短臂2区1带连锁,所以我们认为该家系中致病基因最可能的定位是在16号染色体短臂1区3带。因此,这再次开启了由于16号染色体短臂1区3带上的单个基因导致II型ADO在遗传上具有同质性的可能性。